España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
ArriVent BioPharma
AVBP
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$26.09
0.44
1.72%
At close: -
$26.09
0.00
0.00%
After Hours: Dec 20, 4:03 PM EDT
Get Report
Comment
ArriVent BioPharma (AVBP) Forecast
News
Earnings
ArriVent BioPharma (AVBP) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for ArriVent BioPharma (NASDAQ:AVBP) Stock
ArriVent BioPharma Stock (NASDAQ: AVBP)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 15, 2024
HC Wainwright & Co. Reiterates Buy on ArriVen...
Benzinga Newsdesk
Thursday, November 14, 2024
ArriVent BioPharma shares are trading lower. ...
Benzinga Newsdesk
ArriVent BioPharma Q3 EPS $(0.61) Beats $(0.8...
Benzinga Newsdesk
Wednesday, September 11, 2024
Citigroup Maintains Buy on ArriVent BioPharma...
Benzinga Newsdesk
Tuesday, September 10, 2024
Oppenheimer Reiterates Outperform on ArriVent...
Benzinga Newsdesk
Goldman Sachs Maintains Buy on ArriVent BioPh...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on ArriVent...
Benzinga Newsdesk
Monday, September 09, 2024
ArriVent Announces Proof-Of-Concept Global Ph...
Benzinga Newsdesk
Monday, August 19, 2024
Here's What Could Help ArriVent BioPharma, Inc. Maintain Its Recent Price Strength
Zacks
Friday, August 16, 2024
HC Wainwright & Co. Maintains Buy on ArriVent...
Benzinga Newsdesk
Thursday, August 15, 2024
Oppenheimer Reiterates Outperform on ArriVent...
Benzinga Newsdesk
Wednesday, August 14, 2024
ArriVent BioPharma Q2 EPS $(0.65) Misses $(0....
Benzinga Newsdesk
Monday, August 12, 2024
ArriVent Presents Proof-Of-Concept Phase 1b D...
Benzinga Newsdesk
Thursday, June 06, 2024
HC Wainwright & Co. Reiterates Buy on ArriVen...
Benzinga Newsdesk
Wednesday, June 05, 2024
ArriBent BioPharma Has Collaborated With Jian...
Benzinga Newsdesk
Thursday, May 09, 2024
HC Wainwright & Co. Reiterates Buy on ArriVen...
Benzinga Newsdesk
Wednesday, May 08, 2024
ArriVent BioPharma Q1 EPS $(0.70) Beats $(1.0...
Benzinga Newsdesk
Tuesday, April 30, 2024
HC Wainwright & Co. Initiates Coverage On Arr...
Benzinga Newsdesk
Monday, April 08, 2024
ProfoundBio Discovers The Joys Of Having A Wealthy Owner
The Bamboo Works
Thursday, March 28, 2024
ArriVent BioPharma FY23 EPS $(32.38) Vs $(28....
Benzinga Newsdesk
Tuesday, February 20, 2024
Jefferies Initiates Coverage On ArriVent BioP...
Benzinga Newsdesk
Citigroup Initiates Coverage On ArriVent BioP...
Benzinga Newsdesk
Goldman Sachs Initiates Coverage On ArriVent ...
Benzinga Newsdesk
Friday, February 02, 2024
$10M Bet On ArriVent BioPharma? Check Out These 4 Stocks Insiders Are Buying
Avi Kapoor
Friday, January 26, 2024
ArriVent BioPharma Inc IPO Opens At $24.00
Benzinga Newsdesk
ArriVent BioPharma Shares Indicating $24.00 O...
Benzinga Newsdesk
ArriVent BioPharma Shares Indicating $23.50 O...
Benzinga Newsdesk
ArriVent BioPharma Shares Indicating $23.00 O...
Benzinga Newsdesk
ArriVent BioPharma Shares Indicating $20.50 O...
Benzinga Newsdesk
ArriVent BioPharma Shares Indicating $20 On 1...
Benzinga Newsdesk
ArriVent BioPharma Shares Indicating $20 On 8...
Benzinga Newsdesk
ArriVent BioPharma Prices Upsized Initial Pub...
Benzinga Newsdesk
Thursday, January 25, 2024
Arrivent Biopharma, Inc To Start Trading Tomorrow
Benzinga Insights
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch